ClinicalTrials.Veeva

Menu

Colorectal Cancer Screening Outreach

Yale University logo

Yale University

Status

Not yet enrolling

Conditions

Colo-rectal Cancer

Treatments

Behavioral: Bundled messaging intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT07345676
2000041322

Details and patient eligibility

About

This is a 4 arm pragmatic trial to test a multicomponent intervention designed to improve adherence to colorectal cancer screening.

Enrollment

2,000 estimated patients

Sex

All

Ages

45 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Established adult medicine patient at Cornell Scott Hill health (defined as having a CSHH primary care doctor or >1 adult medicine visits in the last year).
  • Incomplete colorectal cancer screening test defined as an outstanding order for colonoscopy or stool-based CRC screening (e.g., fecal immunochemical test (FIT) or FIT-DNA testing), but no evidence of test completion at the time of randomization. Orders must have been placed between 90-180 days prior to randomization.

OR

  • Abnormal stool-based test without follow-up, defined as an abnormal stool-based test result (e.g., positive FIT or FIT-DNA) with no completed diagnostic colonoscopy within 90 days of the result. Patients who meet this criterion will be included in a non randomized arm of the study.

Exclusion criteria

  • Because this is a pragmatic study of a behavioral intervention to improve colorectal cancer screening adherence, any participants who otherwise meet the inclusion criteria will not be excluded.

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2,000 participants in 4 patient groups

Control-Usual Care
No Intervention group
Description:
Participants will receive a simple text message reminder
Messaging Group A
Experimental group
Description:
Participants will receive a series of outreach messages including texts with two-way messaging capabilities, mailed letter, and a reminder to their clinician. Content of the text message arm will be varied so that patients receive one of three messages (A, B or C).
Treatment:
Behavioral: Bundled messaging intervention
Messaging Group B
Experimental group
Description:
Participants will receive a series of outreach messages including texts with two-way messaging capabilities, mailed letter, and a reminder to their clinician. Content of the text message arm will be varied so that patients receive one of three messages (A, B or C).
Treatment:
Behavioral: Bundled messaging intervention
Messaging Group C
Experimental group
Description:
Participants will receive a series of outreach messages including texts with two-way messaging capabilities, mailed letter, and a reminder to their clinician. Content of the text message arm will be varied so that patients receive one of three messages (A, B or C).
Treatment:
Behavioral: Bundled messaging intervention

Trial contacts and locations

1

Loading...

Central trial contact

Ilana Richman, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems